Skip to main content

Table 2 Association of polygenic scores as a categorical variable (top 5% vs IQR) with incident T2D

From: Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study

 

Scenario 1

Scenario 2

Scenario 3

Scenario 4

n of T2D cases (n in top 5%, n in IQR)

1073 (199, 874)

1002 (184,818)

827 (152, 675)

712 (132, 580)

Total n (n in top 5%, n in IQR)

8092 (736, 7356)

7518 (684, 6834)

5427 (494, 4933)

4032 (367, 3665)

Clinical variables only model

 C-index

0.675

0.752

0.816

0.801

 CRS HR (CI) (p-val)

   

1.71 (1.56–1.88) (1.6e−29)

PGS only model

 C-index

0.608

0.607

0.603

0.608

 PGS HR (CI) (p-val)

2.43 (2.08–2.85) (1.0e−28)

2.40 (2.04–2.83) (7.1e−26)

2.43 (2.03–2.91) (3.5e−22)

2.58 (2.13–3.14) (7.3e−22)

Combined clinical and PGS model

 C-index

0.702

0.769

0.822

0.803

 CRS HR (CI) (p-val)

   

1.71 (1.56–1.88) (6.6e−29)

 PGS HR (CI) (p-val)

2.80 (2.39–3.28) (1.3e−37)

2.65 (2.25–3.12) (3.3e−31)

2.40 (2.0–2.88) (4.9e−21)

2.09 (1.72–2.55) (1.7e−13)

C-index improvement

0.027

0.017

0.006

0.002

LRT p-value

8.77E−31

6.12E−26

5.44E−18

7.09E−12

  1. Longitudinal models were constructed with either clinical variables included in each scenario, polygenic scores (PGS) only, or both the clinical variables and PGS in a combined model. PGS were converted into a categorical value differentiating participants in the top 5% of the PGS compared to those in the interquartile range (IQR) of the PGS. Clinical risk factors in each scenario are as follows: scenario 1 age, sex; scenario 2 age, sex, BMI, family history of T2D, SBP; scenario 3 age, sex, BMI, family history of T2D, SBP, random glucose; scenario 4 age, sex, BMI, family history of T2D, SBP, triglycerides, total cholesterol, and HDL combined into a clinical risk score (CRS) and random glucose. We reported the concordance index (C-index), hazard ratio (HR) for the PGS for being in the top 5% compared to the IQR of the PGS or CRS per standard deviation depending on if they are included in the model, and the log-likelihood ratio test (LRT) p-value from comparing the difference in performance between the combined clinical and PGS model with the clinical variables only model